Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Saposhnikoviae Radix, commonly known as Fang Feng, is a traditional Chinese herbal medicine derived from the dried root of *Saposhnikovia divaricata* (Turcz.) Schischk. It is characterized by its content of bioactive chromones, including prim-O-glucosylcimifugin and cimifugin, as well as coumarins and polyacetylenes. The herb is traditionally used to treat "wind-damp" conditions, including rheumatoid arthritis, headaches, and spasms. Modern pharmacological studies highlight its anti-inflammatory, analgesic, and antioxidant properties. It has been investigated in clinical trials, often as a component of multi-herb formulas like Tong Xie Yao Fang, for the treatment of gastrointestinal disorders such as irritable bowel syndrome (IBS).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on saposhnikoviae radix.